Advancing mRNA-Based Therapeutics for Targeting RAS Mutations with Enhanced Specificity & Versatility
- Addressing RAS mutation subtypes through mRNA technology
- Enhance specificity, tolerability and versatility of RAS-targeted therapies with mRNA
- Altering and adapting mRNA platforms to address challenges of tumor heterogeneity and evolving mutations